GIORDANO, LAURA
GIORDANO, LAURA
DIPARTIMENTO DI COMUNICAZIONE E RICERCA SOCIALE
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
2020 Zucali, Paolo Andrea; Perrino, Matteo; De Vincenzo, Fabio; Giordano, Laura; Cordua, Nadia; D'Antonio, Federica; Santoro, Armando
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab
2021 De Sanctis, Rita; Giordano, Laura; D'Antonio, Federica; Agostinetto, Elisa; Marinello, Arianna; Guiducci, Daniela; Masci, Giovanna; Losurdo, Agnese; Zuradelli, Monica; Torrisi, Rosalba; Santoro, Armando
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
2022 De Carlo, Camilla; Valeri, Marina; Rudini, Noemi; Zucali, Paolo Andrea; Cieri, Miriam; Elefante, Grazia Maria; D'Antonio, Federica; Hurle, Rodolfo; Giordano, Laura; Bressan, Alessandra; Lazzeri, Massimo; Perrino, Matteo; Guazzoni, Giorgio; Terracciano, Luigi Maria; Colombo, Piergiuseppe
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma
2024 De Philippis, Chiara; Zucchinetti, Cristina; Mannina, Daniele; Krampera, Mauro; Zinzani, Pier Luigi; Chiappella, Annalisa; di Rocco, Alice; Orcioulo, Enrico; Tisi, Maria Chiara; Pistolese, Flavio; Giordano, Laura; Santoro, Armando; Bramanti, Stefania
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy
2022 Perrino, Matteo; De Pas, Tommaso; Bozzarelli, Silvia; Giordano, Laura; De Vincenzo, Fabio; Conforti, Fabio; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Santoro, Armando; Zucali, Paolo Andrea
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma | 2020 | Zucali, Paolo Andrea; Perrino, Matteo; De Vincenzo, Fabio; Giordano, Laura; Cordua, Nadia; D'Antonio, Federica; Santoro, Armando | |
| Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab | 2021 | De Sanctis, Rita; Giordano, Laura; D'Antonio, Federica; Agostinetto, Elisa; Marinello, Arianna; Guiducci, Daniela; Masci, Giovanna; Losurdo, Agnese; Zuradelli, Monica; Torrisi, Rosalba; Santoro, Armando | |
| Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer | 2022 | De Carlo, Camilla; Valeri, Marina; Rudini, Noemi; Zucali, Paolo Andrea; Cieri, Miriam; Elefante, Grazia Maria; D'Antonio, Federica; Hurle, Rodolfo; Giordano, Laura; Bressan, Alessandra; Lazzeri, Massimo; Perrino, Matteo; Guazzoni, Giorgio; Terracciano, Luigi Maria; Colombo, Piergiuseppe | |
| Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma | 2024 | De Philippis, Chiara; Zucchinetti, Cristina; Mannina, Daniele; Krampera, Mauro; Zinzani, Pier Luigi; Chiappella, Annalisa; di Rocco, Alice; Orcioulo, Enrico; Tisi, Maria Chiara; Pistolese, Flavio; Giordano, Laura; Santoro, Armando; Bramanti, Stefania | |
| Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy | 2022 | Perrino, Matteo; De Pas, Tommaso; Bozzarelli, Silvia; Giordano, Laura; De Vincenzo, Fabio; Conforti, Fabio; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Santoro, Armando; Zucali, Paolo Andrea |